TSS Clinical Trials Digitalization User Forum 2021
Document
We’re pleased to announce the first TSS Clinical Trials Digitalization User Forum on February 10-11, 2021
How can digitalization transform trials while maintaining quality standards that ensure safe medicine?
What is on this page?
Click to jump to a specific section below.
Digitalization to transform clinical trials to ensure a safe drug to every patient
Together with our most valued partners, we are hosting two half-day virtual sessions with interactive content addressing value-adding digital transformation in clinical trials.
This by-invitation-only user forum set out to discuss best practices for streamlining clinical trial costs and efforts by utilizing digital technologies while moving more towards a patient-centered trial experience.
Some of the topics discussed during the forum were:
- Leveraging IoT to transform clinical trials and lower costs in 2021
- Ensuring a safe drug to every patient with Digital health and Remote inspections
- Creating a holistic end-to-end view that drives sustainability and reduces waste
- Transforming the future. New solutions available
In case you would like to get more information about the event, please contact us.
You may also be interested in
Three approaches for automating clinical supply chains
Our North America VP Evan Hahn, recently presented a webinar where he outlined three different approaches for automating clinical supply chains.
Read moreDownload Whitepaper
5 benefits of adopting digital temperature monitoring solutions
Digital temperature monitoring along every step of the pharmaceutical supply chain is quickly becoming the new norm. Government guidelines like the EU’s Good Distribution Practices (GDP) and the guidelines of UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) have seen to increased uptake of digital temperature monitoring across the Europe’s pharmaceutical industry.
Read moreDownload Whitepaper
Cooperation with Swedish Innovation Authority and University to Optimize Sustainability Procedures
Loggers with reusable components can decrease the carbon footprint by almost 90% compared to disposable. These important discoveries were made during a close collaboration between business, research, and authorities to prepare for more environmentally and socially sustainable business practices.
Read moreDownload WhitepaperYou may also be interested in
What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?
The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read more
Extending TempMonitor BLE to Ultra-Low Temperatures
Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more